SOURCE: Elite Traders Group LLC

January 31, 2013 10:17 ET

Elite Traders Group Evaluates Growth Potential in the Following Micro-Cap Stocks (OTCQB: GSPT), (OTCPINK: QEDN), (OTCQB: LBAS) and (OTCQB: NVLX)

The Following Is an Investment Opinion Being Issued by the Elite Traders Group LLC

NEW YORK, NY--(Marketwire - Jan 31, 2013) - Elite Traders Group Offers Insight On Growth Potential Micro-Cap Stocks -- Terralene Fuels Corp. (OTCQB: GSPT) Terralene Fuel is a patented fuel alternative formulation that is the equivalent of 87 octane regular gasoline and utilizes renewable energy sources in 45% of its composition. Terralene's unique fuel reduces greenhouse gas and other environmental damaging emissions and can be easily integrated into the existing fuel infrastructure. Terralene claims their fuels can easily integrate with our existing fuel delivery infrastructure, work in engines as they are built now and use no food chain organics. These factors should constitute a good long term investment if GSPT's claims are true. The recent market volatility in GSPT shares indicates interest from investors in this technology, rather than a quick buy/sell money making opportunity. With 139 million shares outstanding and a float of only 57 million shares, investors will wonder: how much are their patents worth? The share price jumped to $.02 yesterday and has softened today as the "quick hit" investors get in and out. These shares should find some support at the $.010 - $.015 level as long term investors realize that "going green" is no longer just a catch phrase but a concept to invest in. As always, Elite Traders Group received no compensation for this report.
(Get Full Report)

QED Connect, Inc. (PINKSHEETS: QEDN) announced that it has signed a definitive agreement to acquire Kuma Oil which owns oil and gas rights in the Russian territory of Perm Krai. The potential value of the oil reserves at this location is $525 million. QED offers capital and management assistance in this venture as it has with several other investments and joint ventures in the same markets. Tom Makmann, CEO of QED Connect, commented, "With the entry into the oil & gas business, QED believes it is now in position to implement its strategy and provide our shareholders increased value in 2013." QEDN shares display price volatility with a 52 week range of $.001 - $.10, but these shares have spent a lot of time at the $.02 price recently. Based upon the historical share pricing, QEDN seems to have more upside than downside at today's pricing. With a low market cap of around $5 million and 221 million shares outstanding, it wouldn't take a lot of good news in the oil patch to send these shares upward.
(Get Full Report)

Location Based Technologies, Inc. (OTCQB: LBAS) designs and manufactures personal locators. The Company uses global positioning system technology and cellular transmission to communicate real time location, speed, and directional information to the account holder. Location Based Technologies' products can be used to keep track of people, pets, luggage, and vehicles. Recently LBAS has introduced locating and tracking technology for school buses, with child locator technology, and personal locators sold through retail outlets.

The share price is currently in the middle of its 52 week range of $.12 to $.48 creating room for a good swing to the upside. Longer term investors will not be able to ignore the technology of being able to locate almost anything from any web based device.

The company also enlisted the services of Equities Awareness Group (, a financial marketing and advisory agency that specializes in small and micro-cap companies to broaden their brand awareness. Financially, the thing LBAS lacks most is revenues and the affiliation with EAG should help in that area.

There are only 202 million shares outstanding and the potential for growth in this technology sector is huge.
(Get Full Report)

Nuvilex, Inc. (OTCQB: NVLX), a biotechnology company, announced its subsidiary, KnockOut Technologies, Ltd., has filed a patent in Thailand for all-natural product formulations and their potential use in preventing and treating infections caused by influenza viruses. The natural patent formulations contain a mixture of orange oils. In the biotechnology area of Nuvilex, the company's clinical offerings will include cancer, diabetes and other treatments using the company's cell and gene therapy and live-cell encapsulation technology. Earlier this month NVLX subsidiary Austrianova Singapore has some of its technology recognized by IPI Singapore, a nonprofit whose purpose is to bring profiles and recognition to new biotech discoveries. Shares of NVLX are at the lower end of their 52 week range ($.02 - $.09), trading today at $.027, creating a possible level for longer term investment.

The company has been in business for a few years and has accumulated less than $4 million in liabilities, fairly conservative for a biotech firm. Operating expenses for the 12 months ending 10-31-12 were $1.7 million, also conservative for a biotech firm. Elite Traders Group is your source for unbiased and 100% uncompensated stock analysis.
(Get Full Report)

To Receive More Reports like this one Subscribe free at
Receive mobile alerts text FppAlerts (no spaces) to 25827

Increase Your Day Trading Profits by joining our VIP Pre-promotion/Early Alert Membership For only $29.95/month or $295/year: was developed as a beacon of hope in the micro-cap stock newsletter industry. We always hand-pick our alerts as opposed to biased advertising. Our service typically covers the hottest penny stocks for a longer term than one day offering more potential profit situations. This is why we are the fastest growing community of micro-cap traders on the web.

Please note that all media from Elite Traders Group LLC and is investment opinion only. Elite Traders Group employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This advertisement is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the profiled companies listed here. We do not own shares in any of the above mentioned companies. We have NOT been compensated for the mention of any of the above mentioned companies. We are not currently profiling any of the above mentioned companies to our subscribers.


Contact Information